New drugs for type 2 diabetes: second-line therapy - science report
CADTH
Record ID 32018002209
English
Original Title:
Drugs for type 2 diabetes: second-line therapy review update
Authors' objectives:
The objective of this project is to update a previous CADTH systematic review, network meta-analyses, and cost-effectiveness analysis of second-line therapies for type 2 diabetes. In addition, we aim to review pharmacologic treatments for patients with type 2 diabetes who are at high risk for cardiovascular events.
Details
Project Status:
Completed
URL for protocol:
https://cadth.ca/drugs-type-2-diabetes-project-protocol
Year Published:
2017
URL for published report:
https://cadth.ca/sites/default/files/pdf/TR0012_T2D_Science_Report.pdf
URL for additional information:
https://cadth.ca/drugs-type-2-diabetes-second-line-therapy-review-update
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Canada
Pubmed ID:
30325623
MeSH Terms
- Diabetes Mellitus, Type 2
- Dipeptidyl-Peptidase IV Inhibitors
- Sodium-Glucose Transporter 2 Inhibitors
- Hypoglycemic Agents
- Glucagon-Like Peptide-1 Receptor
- Cardiovascular Diseases
- Costs and Cost Analysis
Keywords
- Diabetes
- Type 2 diabetes
- Drug therapies
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
<p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.